Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Health Tech
Biotech
Altaris scoops up AI drug development outfit for $375M
Healthcare PE firm Altaris is bolstering its presence in the AI drug discovery field through M&A, buying out Simulations Plus.
Eric Sagonowsky
Jun 16, 2026 12:13pm
Merck inks $510M biobucks data partnership with Protillion
Jun 16, 2026 10:06am
Fierce Healthcare
HHS ramps up AI use cases, with most in pre-deployment: BPC
Jun 11, 2026 2:00pm
Alnylam pays Inceptive $30M to transform siRNA design
Jun 4, 2026 4:13am
Hoth Therapeutics’ pivot to AI in space sees stock price rocket
May 28, 2026 10:01am
Fierce Healthcare
GHO Capital, CBC Group to form $21B healthcare investment firm
May 20, 2026 12:30pm